We have located links that may give you full text access.
Defining the Prevalence of Asymptomatic Microscopic Hematuria Among Women With Symptomatic Pelvic Organ Prolapse: Implications for Recommending Subsequent Diagnostic Evaluation.
Urology 2017 May
OBJECTIVE: To evaluate the prevalence of asymptomatic microscopic hematuria (AMH) in women presenting with POP, as well as the relationship of POP stage with AMH.
MATERIALS AND METHODS: Charts of women evaluated in a Female Pelvic Medicine and Reconstructive Surgery clinic between January 2015 and July 2016 were retrospectively reviewed. The prevalence of AMH (≥3 red blood cells per high-powered field on 1 urinalysis) was compared for women with symptomatic POP and those with urinary incontinence (UI) without symptomatic POP. Patient features were compared using chi-square and rank sum tests. Logistic regression was used to evaluate the association of patient factors and AMH.
RESULTS: Overall, 455 of the 498 patients evaluated (91%) had a urinalysis with microscopy. The prevalence of AMH was 3.3% (15 of 455), and was not significantly different between women presenting for prolapse (9 of 264, 3.4%) vs UI (6 of 191, 3.1%; P = .87). The presence of stage ≥2 anterior prolapse was not associated with the risk of AMH (P = .91). Voided vs catheterized specimens were associated with an increased rate of AMH (15.2% vs 2.4%; P = .003). Subsequent hematuria evaluation identified 2 cases of bladder cancer, a urethral mesh erosion, and an asymptomatic kidney stone, with the remaining evaluations negative.
CONCLUSION: We found a prevalence of AMH in women with POP lower than previously reported, and consistent with patients presenting for UI. As such, AMH noted among women with POP should not be ascribed solely to the presence of prolapse.
MATERIALS AND METHODS: Charts of women evaluated in a Female Pelvic Medicine and Reconstructive Surgery clinic between January 2015 and July 2016 were retrospectively reviewed. The prevalence of AMH (≥3 red blood cells per high-powered field on 1 urinalysis) was compared for women with symptomatic POP and those with urinary incontinence (UI) without symptomatic POP. Patient features were compared using chi-square and rank sum tests. Logistic regression was used to evaluate the association of patient factors and AMH.
RESULTS: Overall, 455 of the 498 patients evaluated (91%) had a urinalysis with microscopy. The prevalence of AMH was 3.3% (15 of 455), and was not significantly different between women presenting for prolapse (9 of 264, 3.4%) vs UI (6 of 191, 3.1%; P = .87). The presence of stage ≥2 anterior prolapse was not associated with the risk of AMH (P = .91). Voided vs catheterized specimens were associated with an increased rate of AMH (15.2% vs 2.4%; P = .003). Subsequent hematuria evaluation identified 2 cases of bladder cancer, a urethral mesh erosion, and an asymptomatic kidney stone, with the remaining evaluations negative.
CONCLUSION: We found a prevalence of AMH in women with POP lower than previously reported, and consistent with patients presenting for UI. As such, AMH noted among women with POP should not be ascribed solely to the presence of prolapse.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app